drugset / Trial / NCT02411500

A Pharmacokinetic, Safety and Tolerability Study in Healthy Adult Males

NCT02411500

Phase 1 Completed 18 enrolled Trevena Inc.
RandomizedCrossoverOpen-labelTreatment

Summary

The primary objective of this study is to evaluate the pharmacokinetics of various TRV734 formulations in healthy male subjects.

Timeline

Start
2015-02
Primary completion
2015-03
Completion
2015-03

Drugs

EvaluationDrugModalityDoseRoute
Subject TRV734 Unknown Oral

Indications

No indication recorded.